HYPD

Business Context and Reporting Period

Company: HYPERION DEFI, INC. (formerly Eyenovia, Inc.)
Filing Type: Form 10-Q
Period Ended: September 30, 2025
Business Overview: The Company has pivoted from a traditional ophthalmic technology developer to a digital asset treasury company focused on accumulating HYPE, the native token of the Hyperliquid blockchain. It continues limited development of its Optejet ophthalmic device. The Company operates two segments: Ophthalmic Technology and Digital Assets.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Shift: The Company reported a net income of $6.6 million for the three months ended September 30, 2025, compared to a net loss of $7.9 million in the same period in 2024. This reversal was driven primarily by unrealized and realized gains on digital assets.
• Revenue Composition: Revenue increased to $302,506 (Q3 2025) from $1,625 (Q3 2024), almost entirely derived from HYPE staking rewards and commission income. Ophthalmic revenue is negligible.
• Expense Reduction: Research and Development expenses decreased by 89% ($3.5M to $0.4M) and Selling, General, and Administrative (SG&A) expenses decreased by 30% ($3.7M to $2.6M) compared to Q3 2024, due to the termination of the CHAPERONE study and workforce reductions.
• Balance Sheet Transformation: Total assets increased from $3.7 million (Dec 31, 2024) to $82.8 million (Sept 30, 2025). This is primarily due to the acquisition of HYPE digital assets ($38.0M) and digital intangible assets ($35.0M) funded by capital raises.
• Debt Restructuring: The Company amended its Avenue Loan agreement, extending the maturity to July 2028, reducing the interest rate to 8.0%, and eliminating the conversion option. Current portion of notes payable was reduced to zero.

Guidance, Outlook, and Risks

• Capital Raising: The Company raised approximately $50 million in a private placement of Series A Preferred Stock and $30 million via an At-The-Market (ATM) offering during the nine months ended September 30, 2025. Proceeds were used to purchase HYPE.
• Treasury Strategy: Management expects existing resources to fund operations for the next 12 months. The strategy involves accumulating HYPE, operating a validator node ("Kinetiq x Hyperion"), and deploying tokens into liquid staking (HiHYPE) and asset use services (HAUS) to generate yield.
• Going Concern: The substantial doubt about the Company's ability to continue as a going concern, previously disclosed in the 2024 10-K, has been alleviated due to the successful capital raises and debt restructuring.
• Material Weaknesses: Management identified material weaknesses in internal controls over financial reporting, specifically regarding the accounting for complex non-routine transactions (licensing agreements, debt modifications) and impairment of right-of-use assets.
• Risks: Significant risks include extreme volatility in HYPE token prices, regulatory uncertainty regarding digital assets (potential classification as securities), cybersecurity threats, and the concentration of assets in a single cryptocurrency.

Investor Verification Checklist

• HYPE Valuation: Verify the fair value of HYPE holdings ($37.9M) and HiHYPE ($35.0M) against current market prices, noting the $6.3M impairment loss recognized on HiHYPE during the period.
• Debt Covenants: Review the amended Avenue Loan terms (interest-only period until Jan 2027, 8% rate) and ensure compliance with covenants to avoid acceleration of debt.
• Internal Controls: Assess the remediation plan for the identified material weaknesses in financial reporting controls.
• Preferred Stock Terms: Review the rights of Series A Preferred Stockholders, including the 6% cumulative dividend and conversion ratio (1:3) into common stock.
• Regulatory Status: Monitor SEC and other regulatory actions regarding the classification of HYPE as a security and the Company's status under the Investment Company Act.